Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3405 studies found for:    "Prostatic Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
3 Active, not recruiting Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: METFORMIN;   Drug: Placebo;   Drug: TAXOTERE®
4 Completed Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients
Condition: Prostatic Neoplasm
Interventions: Behavioral: Walking Intervention;   Other: Standard of Care
5 Terminated Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: GM-CSF;   Drug: Ketoconazole;   Drug: Mitoxantrone
6 Completed Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Atrasentan
7 Completed Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
8 Terminated A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: CFG920
9 Completed Safety Study of TAK-700 in Subjects With Prostate Cancer.
Condition: Prostatic Neoplasms
Intervention: Drug: TAK-700
10 Recruiting A Registry of Participants With Prostate Cancer in Asia
Condition: Prostatic Neoplasms
Intervention: Other: No Intervention
11 Completed Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: VELCADE TM (bortezomib) for Injection
12 Completed
Has Results
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Drug: triptorelin embonate (INN)
13 Active, not recruiting Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Conditions: Prostatic Neoplasms;   Low Grade Prostate Cancer
Interventions: Other: Dietary intervention first;   Drug: Drug (Dutasteride) intervention first
14 Completed Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: TroVax;   Drug: GM-CSF
15 Completed Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Paclitaxel polyglumex (Xyotax)
16 Completed
Has Results
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Prednisone;   Drug: SU011248
17 Completed Phase II Study of ASP3550 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: ASP3550
18 Terminated Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: GM-CSF;   Drug: thalidomide;   Drug: docetaxel
19 Recruiting Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: Conventional NSAA;   Drug: LHRHA;   Radiation: External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)
20 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.